5AM Venture Management, LLC
Source: SEC Form 13F · as of Mar 20265AM Venture Management, LLC holds 15 biotech & pharma companies tracked by BioSniper, totaling $228.6M in value as of Mar 2026 (SEC Form 13F).
Companies held
15
Total value held
$228.6M
BioSniper AIPage evidence connected
Prepared research question
What matters most for Entrada Therapeutics, Inc. (TRDA)—catalysts, financial risk and supporting evidence?
Run cited research
Traceable citations · Unknowns marked
| Company | Shares | Value |
|---|---|---|
| TRDAEntrada Therapeutics, Inc. | 4,056,379 | $51.2M |
| CAMPCamp4 Therapeutics Corp | 5,869,091 | $25.9M |
| CNTACentessa Pharmaceuticals plc | 580,945 | $23.1M |
| PHVSPharvaris N.V. | 797,600 | $22.5M |
| MPLTMapLight Therapeutics, Inc. | 950,011 | $19.3M |
| TECXTectonic Therapeutic, Inc. | 606,660 | $18.8M |
| CLDXCelldex Therapeutics, Inc. | 497,270 | $15.8M |
| SRZNSurrozen Inc. | 387,500 | $11.3M |
| ZNTLZentalis Pharmaceuticals, Inc. | 3,947,913 | $9.2M |
| GHRSGH Research PLC | 572,665 | $8.1M |
| BHVNBiohaven Ltd. | 738,972 | $6.3M |
| ALXOALX ONCOLOGY HOLDINGS INC | 3,057,325 | $6.1M |
| SKYESkye Bioscience, Inc. | 9,681,763 | $6.0M |
| RLYBRallybio Corp | 291,788 | $2.6M |
| SLNSilence Therapeutics Plc | 476,200 | $2.5M |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.